- Home
- CCJ vs IQV Comparison
CCJ vs IQV Comparison
Compare CCJ & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CCJ | IQV |
|---|---|---|
| Founded | 1987 | 1982 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.4B | 36.4B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | CCJ | IQV |
|---|---|---|
| Price | $92.76 | $226.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 15 |
| Target Price | $114.38 | ★ $236.93 |
| AVG Volume (30 Days) | ★ 3.2M | 1.4M |
| Earning Date | 11-05-2025 | 02-05-2026 |
| Dividend Yield | ★ 0.18% | N/A |
| EPS Growth | ★ 364.36 | N/A |
| EPS | 0.87 | ★ 7.30 |
| Revenue | $2,487,042,049.00 | ★ $15,904,000,000.00 |
| Revenue This Year | $10.40 | $6.15 |
| Revenue Next Year | $8.64 | $5.39 |
| P/E Ratio | $107.02 | ★ $31.07 |
| Revenue Growth | ★ 23.88 | 3.85 |
| 52 Week Low | $35.00 | $134.65 |
| 52 Week High | $110.16 | $234.30 |
Technical Indicators
Market Signals| Indicator | CCJ | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 55.08 | 57.30 |
| Support Level | $84.29 | $219.91 |
| Resistance Level | $95.10 | $225.80 |
| Average True Range (ATR) | 3.61 | 3.98 |
| MACD | 0.35 | -0.14 |
| Stochastic Oscillator | 70.52 | 96.28 |
Price Performance
Historical ComparisonAbout CCJ Cameco Corporation
Cameco Corp is a provider of uranium needed to generate clean, reliable baseload electricity around the globe. one of those uranium producers. It has three reportable segments, Uranium, Fuel Services, and Westinghouse. It derives maximum revenue from the Westinghouse Segment. It has some projects namely; Millennium, Yeelirrie, Kintyre, and Exploration. The company operates in Canada, Kazakhstan, Germany, Australia, and the United States.
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.